VIRT Q1 2026 Earnings Strong EPS Beat Offsets Flat Market Sentiment Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus CAAP Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Resilience QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges CB Q1 2026 Earnings Solid EPS Beat Amid Premium Growth and Underwriting Discipline KN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Over 4